Online inquiry

IVTScrip™ mRNA-Anti-CD27, 1F5(Cap 0, 2-Thio-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ339MR)

This product GTTS-WQ339MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the monoclonal antibody that targets CD27 gene. The antibody can be applied in Psoriasis research.

Specifications
Product type	mRNA
Modified bases	2-Thio-UTP
5' Cap	Cap 0
Species	Homo sapiens
RefSeq	NM_001242.5
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	939
UniProt ID	P26842

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-CD27, 1F5(Cap 0, 2-Thio-UTP, 120 nt-poly(A)) (GTTS-WQ339MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ231MR	IVTScrip™ mRNA-Anti-B4GALNT1, 14.18 mAb(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	14.18 mAb
GTTS-WQ6306MR	IVTScrip™ mRNA-Anti-TNFRSF10B, CS-1008(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	CS-1008
GTTS-WQ12049MR	IVTScrip™ mRNA-Anti-NRP1, MNRP1685A(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	MNRP1685A
GTTS-WQ2606MR	IVTScrip™ mRNA-Anti-ICOSLG, AMG 557(Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))	mRNA	AMG 557
GTTS-WQ15280MR	IVTScrip™ mRNA-Anti-EGFR, Theraloc(Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	Theraloc
GTTS-WQ5216MR	IVTScrip™ mRNA-Anti-CD22, CAT-8015(Cap 1, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	CAT-8015
GTTS-WQ6363MR	IVTScrip™ mRNA-Anti-MSTN, CSL-362-AML(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	CSL-362-AML
GTTS-WQ11290MR	IVTScrip™ mRNA-Anti-hly, MEDI4893(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	MEDI4893

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST